Diet-induced hyperinsulinemia accelerates growth of androgen-independent PC-3 cells in vitro

Nutrition and Cancer

Volumn 64, Issue 1, 2012, Pages 121-127

  Vikram, Ajit ^a   Jena, Gopabandhu ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GLUCOSE; HORMONE RECEPTOR BLOCKING AGENT; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HYPERINSULINEMIA; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; NONHUMAN; RAT;

ANDROGENS; ANIMALS; BLOOD GLUCOSE; CELL LINE, TUMOR; CELL PROLIFERATION; DIET; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; PEPTIDES; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN;

RATTUS;

EID: 84856860962     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.630556     Document Type: Article

References (45)

1. Boyd DB: Insulin and cancer. Integr Cancer Ther 2, 315-329, 2003. (Pubitemid 37444427)
2. Gallagher EJ and Leroith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 21, 610-618, 2010.
3. Godsland IF: Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) 118, 315-332, 2010.
4. Calle EE, Rodriguez C, Walker-Thurmond K, and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348, 1625-1638, 2003. (Pubitemid 36459468)
5. Kobayashi N, Barnard RJ, Said J, Hong-Gonzalez J, Corman DM,.et al. Effect of low-fat diet on development of prostate cancer andAkt phosphorylation in the Hi-Myc transgenic mouse model. Cancer Res 68, 3066-3073, 2008. (Pubitemid 351556309)
6. Soliman S, Aronson WJ, and Barnard RJ. Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention. Evid Based Complement Alternat Med, 2009.
7. Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM,.et al. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst 99, 1793-1800, 2007. (Pubitemid 351767208)
8. Fan W, Yanase T, Morinaga H, Okabe T, Nomura M,.et al. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor. JBiol Chem282, 7329-7338, 2007. (Pubitemid 47093686)
9. Srinivasan K, Patole PS, Kaul CL, and Ramarao P. Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 26, 327-333, 2004. (Pubitemid 38954807)
10. Vikram A, Jena GB, and Ramarao P. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia. Prostate 70, 79-89, 2010.
11. Vikram A, Jena G, and Ramarao P. Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinemia. Br J Pharmacol 161, 1708-1721, 2010.
12. Haas GP and SakrWA: Epidemiology of prostate cancer. CA Cancer J Clin 47, 273-287, 1997. (Pubitemid 27405933)
13. Tsugane S and Inoue M. Insulin resistance and cancer: Epidemiological evidence. Cancer Sci 101, 1073-1079, 2010.
14. Tuohimaa P, Tenkanen L, Syvala H, Lumme S, Hakulinen T,.et al. Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 16, 302-307, 2007. (Pubitemid 46383350)
15. Hsing AW, Sakoda LC, and Chua S, Jr.: Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 86, S843-S857, 2007.
16. Hammarsten J and Hogstedt B.Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41, 2887-2895, 2005. (Pubitemid 41713128)
17. Hammarsten J and Hogstedt B. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press 13, 47-55, 2004. (Pubitemid 38455847)
18. Moyad MA: Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective. Urology 59, 41-50, 2002. (Pubitemid 34286430)
19. Kirby R, Kirby M, and Fitzpatrick JM: Can lifestyle modification lower the risk of prostate cancer? BJU Int 106, 157-159, 2011.
20. Albanes D, Weinstein SJ, Wright ME, Mannisto S, Limburg PJ,.et al. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 101, 1272-1279, 2009.
21. HsingAW, GaoYT, Chua S, Jr., Deng J, and Stanczyk FZ: Insulin resistance and prostate cancer risk. J Natl Cancer Inst 95, 67-71, 2003. (Pubitemid 36124297)
22. Moore SC, Leitzmann MF, Weinstein SJ, Snyder K, Albanes D,.et al. Insulin resistance-related gene polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 16, 1315-1317, 2007. (Pubitemid 46984980)
23. Tilley WD, Wilson CM, Marcelli M, and McPhaul MJ: Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res 50, 5382-5386, 1990. (Pubitemid 20302992)
24. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17, 16-23, 1979. (Pubitemid 9239413)
25. Vikram A and Jena G: S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats. Biochem Biophys Res Commun 398, 260-265, 2010.
26. Paranjape SA, Chan O, ZhuW,Horblitt AM,McNay EC,.et al. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes 59, 1521-1527, 2010.
27. Schaffer L, Brand CL, Hansen BF, Ribel U, Shaw AC,.et al. A novel high-affinity peptide antagonist to the insulin receptor. Biochem Biophys Res Commun 376, 380-383, 2008.
28. Hammarsten J, Damber JE, Peeker R, Mellstrom D, and Hogstedt B. A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer. Cancer Epidemiol 34, 574-579, 2010.
29. Aronson WJ, Barnard RJ, Freedland SJ, Henning S, Elashoff D,.et al. Growth inhibitory effect of low fat diet on prostate cancer cells: Results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol 183, 345-350, 2010.
30. Barnard RJ, Kobayashi N, and Aronson WJ: Effect of diet and exercise intervention on the growth of prostate epithelial cells. Prostate Cancer Prostatic Dis 11, 362-366, 2008.
31. Barnard RJ, Ngo TH, Leung PS, Aronson WJ, and Golding LA: A lowfat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate 56, 201-206, 2003. (Pubitemid 36918170)
32. Roberts CT, Jr.: IGF-1 and prostate cancer. Novartis Found Symp 262, 193-199; discussion 199-204, 265-268, 2004.
33. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, and Aronson WJ: Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control 13, 929-935, 2002. (Pubitemid 36169476)
34. Mavropoulos JC, Buschemeyer WC III, Tewari AK, Rokhfeld D, Pollak M,.et al. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. Cancer Prev Res (Phila) 2, 557-565, 2009.
35. Thomas JA II, Antonelli JA, Lloyd JC, Masko EM, Poulton SH,.et al. Effect of intermittent fasting on prostate cancer tumor growth in a mouse model. Prostate Cancer Prostatic Dis 13, 350-355, 2010.
36. Kulkarni P and Getzenberg RH: High-fat diet, obesity and prostate disease: The ATX-LPA axis? Nat Clin Pract Urol 6, 128-131, 2009.
37. Vikram A, Jena G, and Ramarao P. Insulin-resistance and benign prostatic hyperplasia: The connection. Eur J Pharmacol 641, 75-81, 2010.
38. Sekine Y, Osei-Hwedieh D, Matsuda K, Raghavachari N, Liu D,.et al. High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate. Prostate, 2011.
39. Vykhovanets EV, Shankar E, Vykhovanets OV, Shukla S, and Gupta S. High-fat diet increases NF-kappaB signaling in the prostate of reporter mice. Prostate 71, 147-156, 2011.
40. de La Serre CB, Ellis CL, Lee J, HartmanAL, Rutledge JC,.et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299, G440-G448, 2010.
41. Perfield JW II, Lee Y, Shulman GI, Samuel VT, Jurczak MJ,.et al. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance. Diabetes 60, 1168-1176, 2011.
42. Ling PR, Andersson C, Strijbosch R, Lee S, Silvestri A,.et al. Effects of glucose or fat calories in total parenteral nutrition on fat metabolism and systemic inflammation in rats. Metabolism 60, 195-205, 2011.
43. Barnard RJ: Prostate cancer prevention by nutritional means to alleviate metabolic syndrome. Am J Clin Nutr 86, S889-S893, 2007.
44. Ngo TH, Barnard RJ, Anton T, Tran C, ElashoffD,.et al. Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence. Cancer Res 64, 1252-1254, 2004. (Pubitemid 38235591)
45. Ngo TH, Barnard RJ, Cohen P, Freedland S, Tran C,.et al. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. Clin Cancer Res 9, 2734-2743, 2003. (Pubitemid 36842120)